Stay updated on Pralsetinib in RET+ Cancer Clinical Trial

Sign up to get notified when there's something new on the Pralsetinib in RET+ Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pralsetinib in RET+ Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page with a 403 header and a Home button, indicating restricted access to the study record rather than an ordinary content update.
    Difference
    21%
    Check dated 2026-09-23T00:24:21.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page footer now displays the site revision as v3.7.0, replacing the previous v3.6.6, reflecting a software revision update.
    Difference
    0.0%
    Check dated 2026-09-15T23:28:32.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6. This indicates a minor update to the page version and routine maintenance rather than any visible content change.
    Difference
    0.0%
    Check dated 2026-09-01T18:07:01.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    A new line '2016 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, recording NIH funding information. This addition provides funding attribution for the ARROW trial within the study record.
    Difference
    0.0%
    Check dated 2026-08-25T16:41:27.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.6.4 to v3.6.5, indicating a software update.
    Difference
    0.0%
    Check dated 2026-08-11T08:23:13.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4, signaling a recent software release update for the page. This is an internal update rather than a change to study data or content.
    Difference
    0.0%
    Check dated 2026-07-28T03:06:31.000Z thumbnail image

Stay in the know with updates to Pralsetinib in RET+ Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pralsetinib in RET+ Cancer Clinical Trial page.